Clinical trial

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

NCT00059358

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-09-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2001-09-01Date precision: month

Registry last updated2009-08-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Hepatitis Cunresolved

Interventions

Ribavirin plus interferon alfa-2bDRUG

RibavirinDRUG · verified · RxNorm: ribavirin

Peginterferon alfa-2bDRUG

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Mapped research locations

San JuanPuerto Rico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00059358 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.